FACULTY:
Rachel Katzenellengogen, MD is division chief of adolescent medicine in the Department of Pediatrics at Indiana University School of Medicine and the Project Director of IU LEAH, an interdisciplinary training program in adolescent and young adult health.
OVERVIEW:
Human Papillomaviruses: Biology, Oncology, Vaccinology, and Advocacy
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Rachel Katzenellengogen, MD, has no financial relationships with ineligible companies to disclose.
The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.
The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The UT Health Science Center San Antonio designates this live activity up to a maximum of 1.00 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
9/20/2024
EXPIRATION DATE:
8/31/2027